Proove Bioscience

















Major Medical Fraud Investigation Involves Opioid Prescribing, Includes Doctors, Facilities, Genetic Testing Lab
e47c00bfe14ad0ac71d0369350b20a9b
G. Nathalee Serrels
4 weeks ago
medical-fraud.jpg

FacebookTwitterSubscribe

Major Medical Fraud Investigation Involves Opioid Prescribing, Includes Doctors, Facilities, Genetic Testing Lab

The Department of Justice announced this week that more than 400 persons were to be charged as a result of a massive crackdown on medical fraud involving prescription opioids. The investigation focused on physicians suspected of the unneeded prescribing of opioids, as well as health care facilities who exploited addicts.

Over $1 billion was fraudulently billed, most of which was paid by the government through the illicit billing of Medicare and Medicaid. Among the accused include a doctor from Houston who allegedly sold thousands of opioid painkillers for cash, and a false rehab center in Florida who reported used gift cards and trips to casinos to lure clients to their facility.

In connection with the medical fraud, Attorney General Sessions stated that close to 300 health care providers were being banned or suspended from federal health care programs participation:

“Too many trusted medical professionals like doctors, nurses, and pharmacists have chosen to violate their oaths and put greed ahead of their patients. Amazingly, some have made their practices into multi-million dollar criminal enterprises. They seem oblivious to the disastrous consequences of their greed.”

addicted-to-painkillers-1.jpg
As additional information has come to light, even more defendants have been uncovered, including three persons associated with Physicians Primary Care of Jeffersonville, Indiana, who reportedly unnecessarily dispensed oxycodone and hydrocodone to patients.

The individuals in question, Jeffrey Campbell, M.D., and nurse practitioners Mark Dyer and Dawn Antle are accused of causing Proove Bioscience, Inc. to fraudulently bill multiple health care programs for genetic testing received by patients treated in their practice that was not for medically legitimate purposes.


YOU MAY ALSO LIKE:

Drug Lord El Guapo To Be Extradicted?

Proove Bioscience, Inc. is a genetic testing company located in Irvine, California. Proove is a controversial company that is now apparently linked to medical fraud. However, at the time of this writing they are not officially charged in the indictment, assuming no intentional wrongdoing on the part of the company.

In February, STAT News reported that the Inspector General for the Department of Health and Human Services, in addition to the FBI, were investigating Proove for potential criminal activity. Past and present employees of the company were interviewed by the FBI and stated that the agents were concentrating on illegal kickbacks to physicians who urged patients to undergo Proove’s DNA testing.

Last month, STAT news reported on Proove again. They said that investigators searched a DNA testing lab and confiscated boxes of documents. They also said that shortly after their February report, Proove lost many large accounts with physicians who ordered tests, and much of the company’s staff was let go.

Doctors were reported to have earned up to $144,000 per year in research fees from Proove, who paid out $30 per test.

Proove issued this statement in June:

“Proove has been subject to a handful of inaccurate stories. We can no longer ignore these false stories based on unreliable sources, and filled with erroneous accusations… spread by a few disgruntled former employees and consultants.”

Research at Proove Biosciences
Proove Biosciences purports to be a “leader in personalized pain medicine” and states that genetic testing they have undergone has been proven effective in clinical research at discovering medicines that are best for treating pain and other health issues. Their website states:

“Proove’s predictive analytics platform improves health care decisions, and we deliver that information through precision medicine profiles. Proove helps clinicians, patients, and payers overcome the burden of pain.”

Last month, the company stated in a press release than 91% of patients in a peer-reviewed study said they experienced pain relief following changes in treatment suggested by its genetic testing. The study, which was led by Katrina Lewis, M.D., was said to be accepted by the Journal of Addiction Research & Therapy for publication.


YOU MAY ALSO LIKE:

Joaquin Guzman - Drug Kingpin Caught by Texting

Unfortunately, at the time of this writing, the research has not yet been published. In fact, the journal’s publisher has been accused by the Federal Trade Commission of deception regarding the true nature of its peer review process.

student.jpg
According to the complaint filed last year, OMICS International has manifested hundreds of open access medical journals that have not thoroughly undergone the peer review process. Also, study authors are charged large fees to have their articles published.

OMICS did publish a study in March by Proove in the Journal of Addiction Research & Therapy that claimed that one of the company’s genetic tests could pinpoint patients at a heightened risk of developing an opioid use disorder, and Proove noted in a press release that the research had undergone the peer-review process.

Another study by Proove was published in the online journal Pharmacogenomics and Personalized Medicine by Dove Medical Press, a similar, suspicious publisher that charges exorbitant fees to authors to have their studies included in medical journals.

~ G. Nathalee Serrels, M.A., Psychology
 






Major Medical Fraud Investigation Involves Opioid Prescribing, Includes Doctors, Facilities, Genetic Testing Lab
e47c00bfe14ad0ac71d0369350b20a9b
G. Nathalee Serrels
4 weeks ago
medical-fraud.jpg

FacebookTwitterSubscribe

Major Medical Fraud Investigation Involves Opioid Prescribing, Includes Doctors, Facilities, Genetic Testing Lab

The Department of Justice announced this week that more than 400 persons were to be charged as a result of a massive crackdown on medical fraud involving prescription opioids. The investigation focused on physicians suspected of the unneeded prescribing of opioids, as well as health care facilities who exploited addicts.

Over $1 billion was fraudulently billed, most of which was paid by the government through the illicit billing of Medicare and Medicaid. Among the accused include a doctor from Houston who allegedly sold thousands of opioid painkillers for cash, and a false rehab center in Florida who reported used gift cards and trips to casinos to lure clients to their facility.

In connection with the medical fraud, Attorney General Sessions stated that close to 300 health care providers were being banned or suspended from federal health care programs participation:

“Too many trusted medical professionals like doctors, nurses, and pharmacists have chosen to violate their oaths and put greed ahead of their patients. Amazingly, some have made their practices into multi-million dollar criminal enterprises. They seem oblivious to the disastrous consequences of their greed.”

addicted-to-painkillers-1.jpg
As additional information has come to light, even more defendants have been uncovered, including three persons associated with Physicians Primary Care of Jeffersonville, Indiana, who reportedly unnecessarily dispensed oxycodone and hydrocodone to patients.

The individuals in question, Jeffrey Campbell, M.D., and nurse practitioners Mark Dyer and Dawn Antle are accused of causing Proove Bioscience, Inc. to fraudulently bill multiple health care programs for genetic testing received by patients treated in their practice that was not for medically legitimate purposes.


YOU MAY ALSO LIKE:

Drug Lord El Guapo To Be Extradicted?

Proove Bioscience, Inc. is a genetic testing company located in Irvine, California. Proove is a controversial company that is now apparently linked to medical fraud. However, at the time of this writing they are not officially charged in the indictment, assuming no intentional wrongdoing on the part of the company.

In February, STAT News reported that the Inspector General for the Department of Health and Human Services, in addition to the FBI, were investigating Proove for potential criminal activity. Past and present employees of the company were interviewed by the FBI and stated that the agents were concentrating on illegal kickbacks to physicians who urged patients to undergo Proove’s DNA testing.

Last month, STAT news reported on Proove again. They said that investigators searched a DNA testing lab and confiscated boxes of documents. They also said that shortly after their February report, Proove lost many large accounts with physicians who ordered tests, and much of the company’s staff was let go.

Doctors were reported to have earned up to $144,000 per year in research fees from Proove, who paid out $30 per test.

Proove issued this statement in June:

“Proove has been subject to a handful of inaccurate stories. We can no longer ignore these false stories based on unreliable sources, and filled with erroneous accusations… spread by a few disgruntled former employees and consultants.”

Research at Proove Biosciences
Proove Biosciences purports to be a “leader in personalized pain medicine” and states that genetic testing they have undergone has been proven effective in clinical research at discovering medicines that are best for treating pain and other health issues. Their website states:

“Proove’s predictive analytics platform improves health care decisions, and we deliver that information through precision medicine profiles. Proove helps clinicians, patients, and payers overcome the burden of pain.”

Last month, the company stated in a press release than 91% of patients in a peer-reviewed study said they experienced pain relief following changes in treatment suggested by its genetic testing. The study, which was led by Katrina Lewis, M.D., was said to be accepted by the Journal of Addiction Research & Therapy for publication.


YOU MAY ALSO LIKE:

Joaquin Guzman - Drug Kingpin Caught by Texting

Unfortunately, at the time of this writing, the research has not yet been published. In fact, the journal’s publisher has been accused by the Federal Trade Commission of deception regarding the true nature of its peer review process.

student.jpg
According to the complaint filed last year, OMICS International has manifested hundreds of open access medical journals that have not thoroughly undergone the peer review process. Also, study authors are charged large fees to have their articles published.

OMICS did publish a study in March by Proove in the Journal of Addiction Research & Therapy that claimed that one of the company’s genetic tests could pinpoint patients at a heightened risk of developing an opioid use disorder, and Proove noted in a press release that the research had undergone the peer-review process.

Another study by Proove was published in the online journal Pharmacogenomics and Personalized Medicine by Dove Medical Press, a similar, suspicious publisher that charges exorbitant fees to authors to have their studies included in medical journals.

~ G. Nathalee Serrels, M.A., Psychology

I love how it says that the physicians caused Proove to fraudulently bill health insurance companies. That's complete garbage. Proove found a loophole to take the accountability off of themselves by having the doctors sign testing agreements. The research assistant's prepared all of the paperwork hand hands the physician a stack and says "here you go, sign please." The patient's are chosen by the research assistant. Each day they give the physician a list of patients they need to see. Criteria is set by Proove: do they have the right diagnosis, the right insurance to bill....etc according to their "research protocol." Yet, if they don't participate in the "study" then they can't have the testing.
 



Major Medical Fraud Investigation Involves Opioid Prescribing, Includes Doctors, Facilities, Genetic Testing Lab
e47c00bfe14ad0ac71d0369350b20a9b
G. Nathalee Serrels
4 weeks ago
medical-fraud.jpg

FacebookTwitterSubscribe

Major Medical Fraud Investigation Involves Opioid Prescribing, Includes Doctors, Facilities, Genetic Testing Lab

The Department of Justice announced this week that more than 400 persons were to be charged as a result of a massive crackdown on medical fraud involving prescription opioids. The investigation focused on physicians suspected of the unneeded prescribing of opioids, as well as health care facilities who exploited addicts.

Over $1 billion was fraudulently billed, most of which was paid by the government through the illicit billing of Medicare and Medicaid. Among the accused include a doctor from Houston who allegedly sold thousands of opioid painkillers for cash, and a false rehab center in Florida who reported used gift cards and trips to casinos to lure clients to their facility.

In connection with the medical fraud, Attorney General Sessions stated that close to 300 health care providers were being banned or suspended from federal health care programs participation:

“Too many trusted medical professionals like doctors, nurses, and pharmacists have chosen to violate their oaths and put greed ahead of their patients. Amazingly, some have made their practices into multi-million dollar criminal enterprises. They seem oblivious to the disastrous consequences of their greed.”

addicted-to-painkillers-1.jpg
As additional information has come to light, even more defendants have been uncovered, including three persons associated with Physicians Primary Care of Jeffersonville, Indiana, who reportedly unnecessarily dispensed oxycodone and hydrocodone to patients.

The individuals in question, Jeffrey Campbell, M.D., and nurse practitioners Mark Dyer and Dawn Antle are accused of causing Proove Bioscience, Inc. to fraudulently bill multiple health care programs for genetic testing received by patients treated in their practice that was not for medically legitimate purposes.


YOU MAY ALSO LIKE:

Drug Lord El Guapo To Be Extradicted?

Proove Bioscience, Inc. is a genetic testing company located in Irvine, California. Proove is a controversial company that is now apparently linked to medical fraud. However, at the time of this writing they are not officially charged in the indictment, assuming no intentional wrongdoing on the part of the company.

In February, STAT News reported that the Inspector General for the Department of Health and Human Services, in addition to the FBI, were investigating Proove for potential criminal activity. Past and present employees of the company were interviewed by the FBI and stated that the agents were concentrating on illegal kickbacks to physicians who urged patients to undergo Proove’s DNA testing.

Last month, STAT news reported on Proove again. They said that investigators searched a DNA testing lab and confiscated boxes of documents. They also said that shortly after their February report, Proove lost many large accounts with physicians who ordered tests, and much of the company’s staff was let go.

Doctors were reported to have earned up to $144,000 per year in research fees from Proove, who paid out $30 per test.

Proove issued this statement in June:

“Proove has been subject to a handful of inaccurate stories. We can no longer ignore these false stories based on unreliable sources, and filled with erroneous accusations… spread by a few disgruntled former employees and consultants.”

Research at Proove Biosciences
Proove Biosciences purports to be a “leader in personalized pain medicine” and states that genetic testing they have undergone has been proven effective in clinical research at discovering medicines that are best for treating pain and other health issues. Their website states:

“Proove’s predictive analytics platform improves health care decisions, and we deliver that information through precision medicine profiles. Proove helps clinicians, patients, and payers overcome the burden of pain.”

Last month, the company stated in a press release than 91% of patients in a peer-reviewed study said they experienced pain relief following changes in treatment suggested by its genetic testing. The study, which was led by Katrina Lewis, M.D., was said to be accepted by the Journal of Addiction Research & Therapy for publication.


YOU MAY ALSO LIKE:

Joaquin Guzman - Drug Kingpin Caught by Texting

Unfortunately, at the time of this writing, the research has not yet been published. In fact, the journal’s publisher has been accused by the Federal Trade Commission of deception regarding the true nature of its peer review process.

student.jpg
According to the complaint filed last year, OMICS International has manifested hundreds of open access medical journals that have not thoroughly undergone the peer review process. Also, study authors are charged large fees to have their articles published.

OMICS did publish a study in March by Proove in the Journal of Addiction Research & Therapy that claimed that one of the company’s genetic tests could pinpoint patients at a heightened risk of developing an opioid use disorder, and Proove noted in a press release that the research had undergone the peer-review process.

Another study by Proove was published in the online journal Pharmacogenomics and Personalized Medicine by Dove Medical Press, a similar, suspicious publisher that charges exorbitant fees to authors to have their studies included in medical journals.

~ G. Nathalee Serrels, M.A., Psychology
I love how it says that the physicians caused Proove to fraudulently bill health insurance companies. That's complete garbage. Proove found a loophole to take the accountability off of themselves by having the doctors sign testing agreements. The research assistant's prepared all of the paperwork hand hands the physician a stack and says "here you go, sign please." The patient's are chosen by the research assistant. Each day they give the physician a list of patients they need to see. Criteria is set by Proove: do they have the right diagnosis, the right insurance to bill....etc according to their "research protocol." Yet, if they don't participate in the "study" then they can't have the testing.
 



Brian Meshkin does not have the ethical and moral foundation to run a healthcare company. Unlike other fields, healthcare is highly structured and procedural. Everything follows a standard process to ensure the safety and security of the patient. This means there is little or no room for creativity. Brian Meshkin is by nature a con man and a thief who will do anything including bending the rules to make money. Such a psychopathic personality inevitably puts him on a collision course with the authorities.

It is shameful the system didn't stop a giant scam like Proove much early and an article like the one done by STAT news took so long to shine the light on Proove. The place was terribly dysfunctional to say the least.

To describe Mr Meshkin as an incompetent CEO will not do justice to the level of incompetence at this company. He made poor decisions in hiring, promotions and in management. Serious ethical violations were so commonplace that one wonders if the products were for dogs and not human beings. Infighting, backstabbing and lack of communication between teams put the company almost in a perpetual state of near anarchy.

Mr Meshkin's greed was on the verge of kleptomania that it was easy to see through his charlatanry and hypocrisy. I hope the Feds put him where he belongs: Prison
 



I read an earlier post that spoke to Rhonda's involvement with signatures ect. It is important to understand that she and others were in lockstep with Joe Matthews as far as doing whatever it took to garner business from as many physician practices as possible. Whether or not that is a hanging offense for her and others is yet to be determined. The bottom line is that Meshkin, Matthews, and Sights from Newfarm over in Kentucky should do jail time for their roles with the Proove pyramid scheme. Collectively, they cheated insurance carriers, doctors, patients, and loyal representatives who helped to market Proove. I would love to see any and all three of these dopes on the street someday.
 












Reading through these post is horrible. It is crazy how most of you call yourselves "Adults".

Yes what ever Brian is going through sucks! I'm sure if you were in his shoes it would just feel like a living nightmare never ending, its taking too much time to get out of it.

All you are doing on here is talking shit. It's going to get really old. I hope 10 years from now you aren't still bitter. There is someone getting diagnosed at this very moment with cancer and all you can do is talk smack.

How about you just live your life and stay positive. I hope this company either shuts downs and pay those who have not gotten paid Or two clean up the company, make that research money, make it ethical and pay everyone back. Hire the right people, listen to the reasons of others so this company doesn't go through this again.

You have to spend money to gain money. There is no easy shortcut. Great software and educated people cost money.

Anthony be quiet. Ben stop lurking. If you are going to write something don't be stupid, obnoxious or childish.

Have a wonderful year ya'll. Please remember do not make this the center of your universe.
 



















Write your reply...